Crossmark

Assessing pricing and affordability of HBV treatment in Japan

Published Online: 2026-02-28

Authors

Suoh, Maito https://orcid.org/0000-0002-7505-9459
Esmaili, Saeed

Eslam, Mohammed

George, Jacob
Funding

Funding for this research was provided by:

National Health and Medical Research Council of Australia (APP1053206)

National Health and Medical Research Council of Australia (APP2001692)

National Health and Medical Research Council of Australia (APP1107178)

National Health and Medical Research Council of Australia (APP1108422)

National Health and Medical Research Council of Australia (APP1196492)

Robert W. Storr Bequest to the Sydney Medical Foundation, The University of Sydney

Cancer Institute NSW (2021/ATRG2028)
License Information

Text and Data Mining valid from 2026-02-28

Version of Record valid from 2026-02-28
More Information

Article History

Received: 18 October 2025

Accepted: 30 January 2026

First Online: 28 February 2026

Declarations

:

: Maito Suoh, Saeed Esmaili, Mohammed Eslam, and Jacob George declare that they have no conflict of interest.

: This article does not contain any studies with human or animal subjects.

Document is current